WASHINGTON -- The U.S. government has cleared the way for the first medical device that enables automated insulin dosing for people with type 2 diabetes. The plastic pod, called the Omnipod 5 ...

The "breakthrough" designation is intended to speed development and expedite review by federal regulators, especially for critical diseases.

Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system.

In brief: Scientists have spent decades trying to find a cure for type 1 diabetes, an autoimmune condition with no known cause. While reprogramming a human body so it stops attacking the pancreatic ...

CAMBRIDGE, MA -- One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent ...